Unlearn.AI’s Post

What Clinical Trial Information Do #VCs And Investors Actually Want? Interesting quote: "This question is less about what the #clinicaltrial is and more about how prepared you are to deliver value in every situation." https://lnkd.in/e4xbSmc2

🚀 Join the Discussion on Diagnostics Regulation Reform! 🧬 As you know clinical diagnostics shape 70% of healthcare decisions, yet regulatory frameworks are struggling to meet market needs. Congress has put out an RFI (see below) to seek our input. 🔍 Crucial questions US Congress is seeking input on: - FDA's role in diagnostics oversight (ex. LDTs) - Integration of AI in regulatory processes - Streamlining approvals for special populations - Expanding diagnostic settings like point-of-care tests 💡 Our input matters! Submit responses to diagnostics@help.senate.gov by April 3, 2024. Let's shape the future of healthcare together! #DiagnosticsReform #HealthcareInnovation #RegulatoryFramework Original RFI: https://lnkd.in/eiFQ4Ns7

We're excited to announce QuantHealth's strategic partnership with Atropos Health, utilizing their extensive federated data model to enhance the accuracy and impact of our trial simulations to the point of care. This partnership marks a significant advancement in delivering AI-powered solutions that benefit patients, physicians, and drug developers alike.

#GenAI could transform #clinical research in five key ways: 1. Clinical trial design 2. Trial feasibility and site selection 3. Patient recruitment and retention 4. Data analysis 5. Regulatory submission and review. But there are barriers to its full adoption – a new report outlines how private and public sector organizations can collaboration to overcome these barriers and use GenAI to benefit #patients, providers and society as a whole. Find our more in this piece by Daniel Reiss, Associate Principal, ZS and Jitka Kolarova: https://lnkd.in/eiDBMYiC

NEWS! QuantHealth Leverages Atropos Health’s Federated Data Model to Bring its Trial Simulations to the Point of Care The Partnership Enables QuantHealth to Train its Simulation Models in Real-Time, and to Deploy its Simulation Models to Benefit Patients, Physicians, and Drug Developers "Utilizing federated data models enhances our ability to set new accuracy standards for clinical trial simulations," said Orr Inbar, CEO and Co-Founder of QuantHealth. "By joining the Atropos Evidence Network, our models will gain access to a large, high-quality dataset that updates in real-time, increasing the quality and relevance of the data that our trial simulations are trained on. Furthermore, by deploying our models on the network, we will be able to validate our models in real-time, on individual patients." Read the full news: https://lnkd.in/dPi6rqEs #healthtech #innovation #clinicaltrial #datamodel #drugdevelopment #patients #wearenina

The clinical trial process can be a lengthy one, but there are good reasons why. Check out our blog to learn more about the process. https://hubs.ly/Q02rQxHL0

📰 Today in PharmaTimes Media Ltd, our Founder and President Gen Li, PhD, MBA discusses the new age of #ClinicalTrials. With nearly a third of phase II trials terminated in 2023, Gen highlights that sponsors must adopt a data-driven approach to improve success rates. 📈 Gen explains how Digital Patient Profiles and Digital Trial Arms help to reduce operational costs, improve patient-centricity, and get life-saving therapies to those who need them faster. 💊 👀 Check out the full article, here. https://lnkd.in/ebPG2P77

Speed up clinical trials with #syntheticdata 🚀

In the world of clinical R&D, the path to innovation is paved with data. Yet, navigating the labyrinth of clinical trial data, with its diverse formats and origins, presents a challenge for biopharma teams. Unifying clinical trial data is not just a technical endeavor, but a strategic imperative essential for clinical research. #datascience #clinicaltrials https://lnkd.in/gPhz3qq3

This insightful article from Clinical Leader sheds light on the future of clinical trials, emphasizing the importance of data sharing and tech-driven approaches. Research shows a growing acceptance of trials among the public, with many recognizing their role in improving lifesaving therapies. https://bit.ly/3yDpoWt At Strados Labs, we're dedicated to advancing respiratory clinical trials. Our RESP® Biosensor provides continuous cough and lung sound data, offering real-time insights into treatment response. By enhancing trial accessibility and engagement, our technology optimizes trial design, accelerates drug development, and improves patient outcomes. #clinicaltrials #clinicalresearch #datainsights #healthtech #healthcareinnovation